Acousia Completes Patient Enrollment for Cisplatin Ototoxicity Prevention Study
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
Sonova has acquired the SilentCloud digital tinnitus management app to fully integrate digital tinnitus therapy into its hearing care ecosystem
The start of the school year often inspires a “Fall refresh,” encouraging professionals to embrace new learning, reconsider established methods, and explore fresh approaches.
A new digital reconstruction study shows that middle-ear hearing loss becomes severe when fluid occupies about half of the ear cavity, offering a non-invasive marker for diagnosing and staging otitis media with effusion.
Regeneron’s DB-OTO gene therapy for genetic hearing loss is one of nine drugs to receive expedited review under FDA's new CNPV program.
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Sottovoce has developed a real-time performance management platform to help orchestras monitor and reduce musicians’ noise exposure, promoting safer, more sustainable hearing health practices across the performing arts industry.
A 14-year-old girl’s vestibular evaluation reveals overlapping signs of vestibular migraine and postural orthostatic tachycardia syndrome (POTS), complicating the diagnosis.
Peter Aksel Villadsen discusses how the Listen To This initiative is driving awareness of hearing health as essential to cognitive function, healthy aging, and overall wellbeing.